Francis L Munier

Summary

Publications

  1. ncbi Ultrasound biomicroscopy evaluation of anterior extension in retinoblastoma: a clinicopathological study
    Alexandre P Moulin
    Jules Gonin Eye Hospital, Avenue de France 15, case postale 133, 1000 Lausanne 7, Switzerland
    Br J Ophthalmol 96:337-40. 2012
  2. ncbi Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma
    Francis L Munier
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Retina 31:566-73. 2011
  3. ncbi Modern cataract surgery for radiation-induced cataracts in retinoblastoma
    Ihab M Osman
    Hopital Ophtalmique Jules Gonin, Lausanne, Switzerland
    Br J Ophthalmol 95:227-30. 2011
  4. ncbi Variable phenotypic expressivity in a Swiss family with autosomal dominant retinitis pigmentosa due to a T494M mutation in the PRPF3 gene
    Veronika Vaclavik
    Hopital Ophtalmique Jules Gonin, Oculogenetic unit 15, Lausanne, Switzerland
    Mol Vis 16:467-75. 2010
  5. ncbi Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salva
    Alessia Pica
    Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, and Department of Anesthesiology, University of Lausanne, Lausanne, Switzerland
    Int J Radiat Oncol Biol Phys 81:1380-6. 2011
  6. ncbi Risk assessment of recurrence in sporadic retinoblastoma using a molecular-based algorithm
    Hoai Viet Tran
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Ophthalmic Genet 33:6-11. 2012
  7. ncbi A new locus for congenital cataract, microcornea, microphthalmia, and atypical iris coloboma maps to chromosome 2
    Hana Abouzeid
    Jules Gonin Eye Hospital, University of Lausanne, Switzerland
    Ophthalmology 116:154-162.e1. 2009
  8. ncbi (106)Ruthenium brachytherapy for retinoblastoma
    Hana Abouzeid
    Jules Gonin Eye Hospital, University of Lausanne, Vaud, Switzerland
    Int J Radiat Oncol Biol Phys 71:821-8. 2008
  9. ncbi New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques
    Francis L Munier
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Clin Experiment Ophthalmol 36:78-89. 2008
  10. ncbi BMI1 loss delays photoreceptor degeneration in Rd1 mice. Bmi1 loss and neuroprotection in Rd1 mice
    Dusan Zencak
    Unit of Oculogenetics, Jules Gonin Eye Hospital, Lausanne, Switzerland
    Adv Exp Med Biol 572:209-15. 2006

Collaborators

Detail Information

Publications17

  1. ncbi Ultrasound biomicroscopy evaluation of anterior extension in retinoblastoma: a clinicopathological study
    Alexandre P Moulin
    Jules Gonin Eye Hospital, Avenue de France 15, case postale 133, 1000 Lausanne 7, Switzerland
    Br J Ophthalmol 96:337-40. 2012
    ..UBM may provide useful criteria governing the indication for enucleation...
  2. ncbi Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma
    Francis L Munier
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Retina 31:566-73. 2011
    ..In this study, we report on the vascular adverse effects observed in our initial cohort of 13 patients...
  3. ncbi Modern cataract surgery for radiation-induced cataracts in retinoblastoma
    Ihab M Osman
    Hopital Ophtalmique Jules Gonin, Lausanne, Switzerland
    Br J Ophthalmol 95:227-30. 2011
    ..This study analyses the safety and functional results of such surgery...
  4. ncbi Variable phenotypic expressivity in a Swiss family with autosomal dominant retinitis pigmentosa due to a T494M mutation in the PRPF3 gene
    Veronika Vaclavik
    Hopital Ophtalmique Jules Gonin, Oculogenetic unit 15, Lausanne, Switzerland
    Mol Vis 16:467-75. 2010
    ....
  5. ncbi Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salva
    Alessia Pica
    Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, and Department of Anesthesiology, University of Lausanne, Lausanne, Switzerland
    Int J Radiat Oncol Biol Phys 81:1380-6. 2011
    ..To determine the local control and complication rates for children with papillary and/or macular retinoblastoma progressing after chemotherapy and undergoing stereotactic radiotherapy (SRT) with a micromultileaf collimator...
  6. ncbi Risk assessment of recurrence in sporadic retinoblastoma using a molecular-based algorithm
    Hoai Viet Tran
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Ophthalmic Genet 33:6-11. 2012
    ....
  7. ncbi A new locus for congenital cataract, microcornea, microphthalmia, and atypical iris coloboma maps to chromosome 2
    Hana Abouzeid
    Jules Gonin Eye Hospital, University of Lausanne, Switzerland
    Ophthalmology 116:154-162.e1. 2009
    ..Molecular analysis of this phenotype may improve our understanding of anterior segment development...
  8. ncbi (106)Ruthenium brachytherapy for retinoblastoma
    Hana Abouzeid
    Jules Gonin Eye Hospital, University of Lausanne, Vaud, Switzerland
    Int J Radiat Oncol Biol Phys 71:821-8. 2008
    ..To evaluate the efficacy of (106)Ru plaque brachytherapy for the treatment of retinoblastoma...
  9. ncbi New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques
    Francis L Munier
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Clin Experiment Ophthalmol 36:78-89. 2008
    ..Finally, some guidelines are provided regarding indications to modern radiation therapy in patients requiring second-line or salvage treatment for intraocular retinoblastoma, as well as adjuvant therapy for orbital involvement...
  10. ncbi BMI1 loss delays photoreceptor degeneration in Rd1 mice. Bmi1 loss and neuroprotection in Rd1 mice
    Dusan Zencak
    Unit of Oculogenetics, Jules Gonin Eye Hospital, Lausanne, Switzerland
    Adv Exp Med Biol 572:209-15. 2006
    ..In this chapter, we will first provide a brief review of our work on the cortical NSCs and introduce the Bmi1 oncogene, thus offering a rational to our observations on the retina...
  11. ncbi PAX6 aniridia and interhemispheric brain anomalies
    Hana Abouzeid
    Jules Gonin Eye Hospital, University of Lausanne, Switzerland
    Mol Vis 15:2074-83. 2009
    ..To report the clinical and genetic study of patients with autosomal dominant aniridia...
  12. ncbi Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis
    Hana Abouzeid
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Mol Vis 15:771-7. 2009
    ..To study phenotype-genotype correlation in patients who have retinoma, which is a benign tumor resembling the post irradiation regression pattern of retinoblastoma (RB)...
  13. ncbi Ten novel RB1 gene mutations in patients with retinoblastoma
    Hana Abouzeid
    Jules Gonin Eye Hospital, Lausanne, Switzerland
    Mol Vis 13:1740-5. 2007
    ....
  14. ncbi Lentiviral vectors containing a retinal pigment epithelium specific promoter for leber congenital amaurosis gene therapy. Lentiviral gene therapy for LCA
    Alexis-Pierre Bemelmans
    Oculogenetics Unit, , Lausanne, Switzerland
    Adv Exp Med Biol 572:247-53. 2006
  15. ncbi Benign pineal cysts in children with bilateral retinoblastoma: a new variant of trilateral retinoblastoma?
    Maja Beck Popovic
    Pediatric Hematology Oncology Unit, University Hospital, Lausanne, Switzerland
    Pediatr Blood Cancer 46:755-61. 2006
    ..Patients with hereditary retinoblastoma (Rb) develop in 4%-8% a malignant midline tumor called trilateral Rb (TRb). We report in this study on benign pineal cysts observed in patients investigated for TRb...
  16. ncbi Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate
    Kriss Canola
    Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, 1004 Lausanne, Switzerland
    Invest Ophthalmol Vis Sci 48:446-54. 2007
    ....